For example, a three-lncRNA signature accurately predicts the survival of patients with esophageal squamous cell carcinoma (ESCC) [22], and measurement of the lncRNA prostate cancer antigen 3 gene (PCA3) in patient urine samples is an effective method for the diagnosis of early prostate cancer [23]. This evidence concerns the gene PCA3 and prostate cancer.